Valeant Pharmaceuticals is paying $54 million to settle kickback charges against its Salix unit.
Takeda Pharmaceutical and Theravance Biopharma entered into a global license, development and commercialization agreement.
A budget impact analysis estimated when the cost savings are amortized over one million lives, Commonwealth Laboratories’ IBSchek will save healthcare payers more than $3.5 million annually.
Cantel Medical stock saw a 7.05 percent-drop in short interest.
New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment.
More articles on GI/endoscopy:
Cantel Medical’s short interest drops 7.05%: 3 points
Use of Allurion Technologies’ Elipse gastric balloon results in successful weight loss: 4 things to know
Healthmark adds Endo Bin & Trolley Set; enables controlled delivery & retrievable system for endoscopes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
